Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia: the ARCADIA-POL study.

Dobrowolski P, Januszewicz M, Klisiewicz A, Prejbisz A, Warchoł-Celińska E, Michałowska I, Florczak E, Kożuch K, Hanus K, Aniszczuk-Hybiak A, Witowicz H, Witkowski A, Kądziela J, Kabat M, Madej K, Nazarewski S, Tykarski A, Stryczyński Ł, Szczerbo-Trojanowska M, Światłowski Ł, Kosiński P, Widecka K, Januszewicz A, Hoffman P.

J Hypertens. 2018 Mar 9. doi: 10.1097/HJH.0000000000001706. [Epub ahead of print]

PMID:
29528871
2.

Do we need invasive confirmation of cardiac magnetic resonance results?

Siastała P, Kądziela J, Małek ŁA, Śpiewak M, Lech K, Witkowski A.

Postepy Kardiol Interwencyjnej. 2017;13(1):26-31. doi: 10.5114/aic.2017.66183. Epub 2017 Mar 10.

3.

Forty-two-year-old female patient with resistant hypertension, bilateral renal fibromuscular dysplasia and intracranial aneurysm.

Kaszuba AM, Prejbisz A, Kądziela J, Ambroziak U, Szczerbo-Trojanowska M, Januszewicz A.

Postepy Kardiol Interwencyjnej. 2016;12(4):386-388. Epub 2016 Nov 17. No abstract available.

4.

A single-centre experience of the implementation of adrenal vein sampling procedure: the impact on the diagnostic work-up in primary aldosteronism.

Kądziela J, Prejbisz A, Michałowska I, Kołodziejczyk-Kruk S, Schultze Kool L, Kabat M, Janaszek-Sitkowska H, Toutounchi S, Gałązka Z, Ambroziak U, Bednarczuk T, Ptasińska-Wnuk D, Hoffmann M, Januszewicz M, Januszewicz A, Witkowski A.

Kardiol Pol. 2017;75(1):28-34. doi: 10.5603/KP.a2016.0166. Epub 2016 Nov 23.

5.

Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.

Dekkers T, Prejbisz A, Kool LJS, Groenewoud HJMM, Velema M, Spiering W, Kołodziejczyk-Kruk S, Arntz M, Kądziela J, Langenhuijsen JF, Kerstens MN, van den Meiracker AH, van den Born BJ, Sweep FCGJ, Hermus ARMM, Januszewicz A, Ligthart-Naber AF, Makai P, van der Wilt GJ, Lenders JWM, Deinum J; SPARTACUS Investigators.

Lancet Diabetes Endocrinol. 2016 Sep;4(9):739-746. doi: 10.1016/S2213-8587(16)30100-0. Epub 2016 Jun 17.

PMID:
27325147
6.

Stent sizing strategies in renal artery stenting: the comparison of conventional invasive renal angiography with renal computed tomographic angiography.

Kadziela J, Michalowska I, Pregowski J, Janaszek-Sitkowska H, Lech K, Kabat M, Staruch A, Januszewicz A, Witkowski A.

Postepy Kardiol Interwencyjnej. 2016;12(2):116-21. doi: 10.5114/aic.2016.59361. Epub 2016 May 11.

7.

Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).

Kądziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Więcek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A.

Kardiol Pol. 2016;74(9):961-8. doi: 10.5603/KP.a2016.0058. Epub 2016 May 10.

8.

Ruptured plaque in the renal artery by optical coherence tomography.

Tyczyński P, Kądziela J, Michałowska I, Puciłowska B, Witkowski A.

Kardiol Pol. 2016;74(2):193. doi: 10.5603/KP.2016.0022. No abstract available.

9.

7D.11: RETINAL ARTERIOLAR STRUCTURE IN PATIENTS WITH PRIMARY ALDOSTERONISM.

Gosk-Przybylek M, Harazny J, Binczyk E, Szymanek K, Prejbisz A, Szaflik J, Kolodziejczyk-Kruk S, Pregowska-Chwala B, Makowiecka-Ciesla M, Janas J, Kadziela J, Warchol-Celinska E, Ambroziak U, Bednarczuk T, Toutounchi S, Narkiewicz K, Reincke M, Szaflik J, Schmieder RE, Januszewicz A.

J Hypertens. 2015 Jun;33 Suppl 1:e103. doi: 10.1097/01.hjh.0000467628.01505.f8.

PMID:
26102658
10.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

11.

Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial.

Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Ott C, Schmieder RE; ROX CONTROL HTN Investigators.

Lancet. 2015 Apr 25;385(9978):1634-41. doi: 10.1016/S0140-6736(14)62053-5. Epub 2015 Jan 23. Erratum in: Lancet. 2016 Feb 13;387(10019):648. Lancet. 2015 Apr 25;385(9978):1622.

PMID:
25620016
12.

Relationship between hemodynamic parameters of renal artery stenosis and the changes of kidney function after renal artery stenting in patients with hypertension and preserved renal function.

Kądziela J, Prejbisz A, Michałowska I, Adamczak M, Warchoł-Celińska E, Pregowska-Chwała B, Januszewicz M, Więcek A, Januszewicz A, Witkowski A.

Blood Press. 2015 Feb;24(1):30-4. doi: 10.3109/08037051.2014.958304. Epub 2014 Sep 30.

PMID:
25268986
13.

Renal denervation after the symplicity HTN-3 trial.

Warchoł-Celińska E, Januszewicz A, Prejbisz A, Kądziela J.

Postepy Kardiol Interwencyjnej. 2014;10(2):75-7. doi: 10.5114/pwki.2014.43509. Epub 2014 Jun 26. No abstract available.

14.

Authors' response.

Kądziela J.

Cardiol J. 2014;21(3):330. doi: 10.5603/CJ.2014.0047. No abstract available.

PMID:
24961552
15.

Recurrent restenosis in saphenous vein graft. What is the next step?

Tyczyński P, Kądziela J, Pręgowski J, Demkow M, Witkowski A.

Kardiol Pol. 2014;72(4):388. doi: 10.5603/KP.2014.0078. No abstract available.

16.

Renal denervation - current evidence and perspectives.

Warchoł-Celińska E, Prejbisz A, Florczak E, Kądziela J, Witkowski A, Januszewicz A.

Postepy Kardiol Interwencyjnej. 2013;9(4):362-8. doi: 10.5114/pwki.2013.38866. Epub 2013 Nov 18. Review.

17.

Percutaneous angioplasty of the only patent renal artery - treatment of choice for end-stage heart failure.

Kądziela J, Tyczyński P, Michałowska I, Konka M, Duda B, Witkowski A.

Postepy Kardiol Interwencyjnej. 2013;9(1):83-5. doi: 10.5114/pwki.2013.34031. Epub 2013 Mar 21.

18.

Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease.

Prejbisz A, Kądziela J, Lewandowski J, Florczak E, Zylińska E, Kłopotowski M, Witkowski A, Januszewicz A.

Clin Res Cardiol. 2014 Mar;103(3):251-3. doi: 10.1007/s00392-013-0647-1. Epub 2013 Dec 10. No abstract available.

19.

Advanced computed tomographic anatomical and morphometric plaque analysis for prediction of fractional flow reserve in intermediate coronary lesions.

Opolski MP, Kepka C, Achenbach S, Pregowski J, Kruk M, Staruch AD, Kadziela J, Ruzyllo W, Witkowski A.

Eur J Radiol. 2014 Jan;83(1):135-41. doi: 10.1016/j.ejrad.2013.10.005. Epub 2013 Oct 21.

PMID:
24211037
20.

Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study.

Kruk M, Menon V, Kądziela J, Sadowski Z, Rużyłło W, Janas J, Roik M, Opolski G, Zmudka K, Czunko P, Kurowski M, Busz-Papież B, Zinka E, Jablonski W, Jaworska K, Raczynska A, Skonieczny G, Forman S, Li D, Hochman J.

BMC Cardiovasc Disord. 2013 Oct 24;13:91. doi: 10.1186/1471-2261-13-91.

Supplemental Content

Loading ...
Support Center